183 related articles for article (PubMed ID: 32009805)
1. Tanshinone IIA Reverses Oxaliplatin Resistance In Human Colorectal Cancer Via Inhibition Of ERK/Akt Signaling Pathway.
Zhang Y; Ge T; Xiang P; Zhou J; Tang S; Mao H; Tang Q
Onco Targets Ther; 2019; 12():9725-9734. PubMed ID: 32009805
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA reverses oxaliplatin resistance in colorectal cancer through microRNA-30b-5p/AVEN axis.
Ge T; Zhang Y
Open Med (Wars); 2022; 17(1):1228-1240. PubMed ID: 35892081
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA Reverses Gefitinib-Resistance In Human Non-Small-Cell Lung Cancer Via Regulation Of VEGFR/Akt Pathway.
Wang R; Luo Z; Zhang H; Wang T
Onco Targets Ther; 2019; 12():9355-9365. PubMed ID: 31807016
[TBL] [Abstract][Full Text] [Related]
4. Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of TGF-β/Smad2/3 signaling pathway.
Yin J; Wang L; Wang Y; Shen H; Wang X; Wu L
Onco Targets Ther; 2019; 12():3893-3903. PubMed ID: 31190888
[No Abstract] [Full Text] [Related]
5. Tanshinone IIA induces apoptosis and autophagy in acute monocytic leukemia via downregulation of PI3K/Akt pathway.
Zhang Y; Geng Y; He J; Wu D; Zhang T; Xue L; Zhang L; He A
Am J Transl Res; 2019; 11(5):2995-3006. PubMed ID: 31217869
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA promotes IL2-mediated SW480 colorectal cancer cell apoptosis by triggering INF2-related mitochondrial fission and activating the Mst1-Hippo pathway.
Qian J; Fang D; Lu H; Cao Y; Zhang J; Ding R; Li L; Huo J
Biomed Pharmacother; 2018 Dec; 108():1658-1669. PubMed ID: 30372868
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA Alleviates the Biological Characteristics of Colorectal Cancer via Activating the ROS/JNK Signaling Pathway.
Qian J; Cao Y; Zhang J; Li L; Wu J; Yu J; Huo J
Anticancer Agents Med Chem; 2023; 23(2):227-236. PubMed ID: 35593352
[TBL] [Abstract][Full Text] [Related]
8. Emodin reverses 5-Fu resistance in human colorectal cancer via downregulation of PI3K/Akt signaling pathway.
Li T; Si W; Zhu J; Yin L; Zhong C
Am J Transl Res; 2020; 12(5):1851-1861. PubMed ID: 32509181
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA Affects Autophagy and Apoptosis of Glioma Cells by Inhibiting Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Pathway.
Ding L; Ding L; Wang S; Wang S; Wang W; Wang W; Lv P; Lv P; Zhao D; Zhao D; Chen F; Chen F; Meng T; Meng T; Dong L; Dong L; Qi L; Qi L
Pharmacology; 2017; 99(3-4):188-195. PubMed ID: 27889779
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA induces apoptosis of ovarian cancer cells
Zhang X; Zhou Y; Gu YE
Oncol Lett; 2019 Feb; 17(2):1896-1902. PubMed ID: 30675253
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA promotes apoptosis by downregulating BCL2 and upregulating TP53 in triple-negative breast cancer.
Liu J; Zhang C; Liu S; Wang X; Wu X; Hao J
Naunyn Schmiedebergs Arch Pharmacol; 2023 Feb; 396(2):365-374. PubMed ID: 36374307
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA reverses EGF- and TGF-β1-mediated epithelial-mesenchymal transition in HepG2 cells via the PI3K/Akt/ERK signaling pathway.
Zhang L; Lin W; Chen X; Wei G; Zhu H; Xing S
Oncol Lett; 2019 Dec; 18(6):6554-6562. PubMed ID: 31807174
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA regulates colorectal cancer apoptosis via attenuation of Parkin‑mediated mitophagy by suppressing AMPK/Skp2 pathways.
He L; Gu K
Mol Med Rep; 2018 Aug; 18(2):1692-1703. PubMed ID: 29845197
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression.
Su CC
Anticancer Res; 2014 Dec; 34(12):7097-110. PubMed ID: 25503137
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone IIA inhibits human gastric carcinoma AGS cell growth by decreasing BiP, TCTP, Mcl‑1 and Bcl‑xL and increasing Bax and CHOP protein expression.
Su CC
Int J Mol Med; 2014 Dec; 34(6):1661-8. PubMed ID: 25270224
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA inhibits BT-20 human breast cancer cell proliferation through increasing caspase 12, GADD153 and phospho-p38 protein expression.
Yan MY; Chien SY; Kuo SJ; Chen DR; Su CC
Int J Mol Med; 2012 May; 29(5):855-63. PubMed ID: 22322382
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way.
Xie J; Liu JH; Liu H; Liao XZ; Chen Y; Lin MG; Gu YY; Liu TL; Wang DM; Ge H; Mo SL
BMC Cancer; 2016 Nov; 16(1):899. PubMed ID: 27863471
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA Inhibits Epithelial-to-Mesenchymal Transition Through Hindering β-Arrestin1 Mediated β-Catenin Signaling Pathway in Colorectal Cancer.
Song Q; Yang L; Han Z; Wu X; Li R; Zhou L; Liu N; Sui H; Cai J; Wang Y; Ji Q; Li Q
Front Pharmacol; 2020; 11():586616. PubMed ID: 33192529
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA induces apoptosis in human lung cancer A549 cells through the induction of reactive oxygen species and decreasing the mitochondrial membrane potential.
Chiu TL; Su CC
Int J Mol Med; 2010 Feb; 25(2):231-6. PubMed ID: 20043132
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of Tanshinone IIA on inverted formin-2 protects HaCaT cells against oxidative injury via regulating mitochondrial stress.
Xie Z; Zhou Y; Duan X; Yang L
J Recept Signal Transduct Res; 2019 Apr; 39(2):134-145. PubMed ID: 31354004
[No Abstract] [Full Text] [Related]
[Next] [New Search]
